Press "Enter" to skip to content

Patent delisted for Novartis Pharms drug PROMACTA

0
Copyright © DrugPatentWatch. Originally published at Patent delisted for Novartis Pharms drug PROMACTA

Annual Drug Patent Expirations for PROMACTA
Promacta is a drug marketed by Novartis Pharms Corp and is included in two NDAs. It is available from two suppliers. There are fourteen patents protecting this drug and two Paragraph IV challenges.

The generic ingredient in PROMACTA is eltrombopag olamine. Two suppliers are listed for this compound. Additional details are available on the eltrombopag olamine profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at Patent delisted for Novartis Pharms drug PROMACTA
Do NOT follow this link or you will be banned from the site!